Clinical Trial

Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Yufeng Ningxin, a traditional Chinese medicine, has demonstrated potential antihypertensive effects in animal studies and small clinical trials, but has not yet been rigorously evaluated in large randomized clinical trials. Here, the investigators conducted a double-blind, randomized controlled trial to assess the efficacy and safety of Yufeng Ningxin tablets in patients with hypertension.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-03
Trial Details
NCT Number NCT07607275
Lead Sponsor Beijing Anzhen Hospital
Conditions Hypertension, Essential (Primary) Hypertension
Enrollment 350 participants
Start Date 2026-05-15
Primary Completion 2027-12-01 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-02